Contact Client login
Regimbeau's insights

Exploring the present to provide you with the keys to the future

As a leading IP law firm, Regimbeau has always considered knowledge sharing to be the logical corollary of its excellent IP expertise.

Our experts regularly write for major international IP journals and contribute to Regimbeau’s reputation.

Last news #Unitary Patent #Mediation #Immunotherapy #Pharmaceuticals
Patents
All
Undo all
Undo all
Undo all
0 100
Réinitialiser
Publications - 14 Nov 2025

A new hope for biotech companies in the USA: the PERA bill and patent eligibility of diagnostics and gene or cell therapies

By Cécile Puech, Ph.D
#Patents #Biotechnology #Diagnosis #MedTech
Publications - 23 Oct 2025

Appeal proceedings before the Paris Court of Appeal following a patent opposition decision – the admissibility of new auxiliary claims is not self-evident

By Stéphanie Massin Célaire and Alexandre Metzger
Publications - 01 Jul 2025

G1/24: The description of a patent must be referred when interpreting the claims… and so what?

By Yves de Saint-Pern
#Patents #Brevets
Publications - 03 Jun 2025

Patentability of dosage regimen claims

By Gaëlle Jan, Ph.D
#Patents #Pharmaceuticals
Publications - 28 Apr 2025

On the patentability of mushrooms according to the UPC

By Aurélia Vavasseur, Ph.D
#Patents #UPC #Brevets #JUB #Patentability #Biotechnology #Biotechnology
Publications - 04 Mar 2025

News regarding cross-border patent litigation!

By Aurélien Grimberg
#Patents #UPC
Publications - 06 Feb 2025

Protection of Diagnostic Methods: State of Play in Different Regions of the World

By Armelle Leonard
#Patents #Brevets #Biotechnology #Biotechnology #Diagnosis #MedTech
Publications - 12 Nov 2024

Obtaining the technical effect across the entire scope of the claims: consider it right from the drafting stage! 

By Aurélien Grimberg and Sylvain Thivillier
#Patents
Publications - 01 Oct 2024

Amendments to legislation in India

By Emmanuelle Levy and Valérie Marcinkowski
#Patents #Brevets
Publications - 24 Sep 2024

Protection through patents and designs: complementary tools

By Emmanuel Potdevin
#Patents #Designs
Publications - 24 Jul 2024

Major and minor cannabinoids: current patent situation

By Lucile Vernoux, Ph.D and Isabelle Mary
#Patents #Biotechnology #Strategy
Publications - 15 May 2024

« Dupes » : don't despair, industrial property is your answer!

By Martine Bloch-Weill
#Patents #Copyright #Designs #Trademarks
Regimbeau Institute

Find out more about our next formations and webinars

Take part in the futur meetings

Apply
Powered by  GDPR Cookie Compliance (opens in a new tab)
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.